Cargando…

Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease

Caveolin-1 (CAV1) is a crucial regulator of lipid accumulation and metabolism. Previous studies have shown that global Cav1 deficiency affects lipid metabolism and hepatic steatosis. We aimed to analyze the consequences of hepatocyte-specific Cav1 knockout under healthy conditions and upon non-alcoh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Mei, Piorońska, Weronika, Wang, Sai, Nwosu, Zeribe Chike, Sticht, Carsten, Wang, Shanshan, Gao, Yan, Ebert, Matthias Philip, Dooley, Steven, Meyer, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005160/ https://www.ncbi.nlm.nih.gov/pubmed/32029710 http://dx.doi.org/10.1038/s41419-020-2295-5

Ejemplares similares

Caveolin-1 Impacts on TGF-β Regulation of Metabolic Gene Signatures in Hepatocytes
por: Han, Mei, et al.
Publicado: (2020)

Caveolin-1 in the regulation of cell metabolism: a cancer perspective
por: Nwosu, Zeribe Chike, et al.
Publicado: (2016)

Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes
por: Piorońska, Weronika, et al.
Publicado: (2021)

Identification of the Consistently Altered Metabolic Targets in Human Hepatocellular Carcinoma
por: Nwosu, Zeribe Chike, et al.
Publicado: (2017)

Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours
por: Nwosu, Zeribe C., et al.
Publicado: (2018)

Correction to: Liver cancer cell lines distinctly mimic the metabolic gene expression pattern of the corresponding human tumours
por: Nwosu, Zeribe C., et al.
Publicado: (2018)

The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells
por: Moreno-Càceres, Joaquim, et al.
Publicado: (2017)

Distinct dedifferentiation processes affect caveolin-1 expression in hepatocytes
por: Meyer, Christoph, et al.
Publicado: (2013)

Caveolin-1 abrogates TGF-β mediated hepatocyte apoptosis
por: Meyer, C, et al.
Publicado: (2013)

Severe metabolic alterations in liver cancer lead to ERK pathway activation and drug resistance
por: Nwosu, Zeribe Chike, et al.
Publicado: (2020)

Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver Myofibroblasts
por: Nwosu, Zeribe C., et al.
Publicado: (2016)

Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis
por: Yokomori, Hiroaki, et al.
Publicado: (2020)

Role of caveolin‐1 in hepatocellular carcinoma arising from non‐alcoholic fatty liver disease
por: Takeda, Makoto, et al.
Publicado: (2018)

Ethanol sensitizes hepatocytes for TGF-β-triggered apoptosis
por: Gaitantzi, Haristi, et al.
Publicado: (2018)

Tolerance of repeated toxic injuries of murine livers is associated with steatosis and inflammation
por: Hammad, Seddik, et al.
Publicado: (2023)

Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease
por: Lakhani, Hari Vishal, et al.
Publicado: (2018)

Caveolar Fatty Acids and Acylation of Caveolin-1
por: Cai, Qian, et al.
Publicado: (2013)

Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17
por: Moreno-Càceres, J, et al.
Publicado: (2014)

Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
por: Lyall, Marcus J., et al.
Publicado: (2018)

Caveolin-1 Alleviates Acetaminophen—Induced Hepatotoxicity in Alcoholic Fatty Liver Disease by Regulating the Ang II/EGFR/ERK Axis
por: Xin, Jiao, et al.
Publicado: (2022)

Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease
por: Wang, Huan, et al.
Publicado: (2023)

Caveolin-1 Protects B6129 Mice against Helicobacter pylori Gastritis
por: Hitkova, Ivana, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor
por: Takeichi, Yukina, et al.
Publicado: (2021)

Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease
por: Legaki, Aigli-Ioanna, et al.
Publicado: (2022)

Hepatocyte nuclear factor 4α in the pathogenesis of non-alcoholic fatty liver disease
por: Pan, Xiaoli, et al.
Publicado: (2022)

The protective roles of augmenter of liver regeneration in hepatocytes in the non-alcoholic fatty liver disease
por: Dong, Yuan, et al.
Publicado: (2022)

Role of caveolin-1 in chronic postsurgical pain in rats
por: Huang, Sai-Sai, et al.
Publicado: (2021)

Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease
por: Zhang, Yizhi, et al.
Publicado: (2022)

Caveolin-1 Alleviates Acetaminophen-Induced Fat Accumulation in Non-Alcoholic Fatty Liver Disease by Enhancing Hepatic Antioxidant Ability via Activating AMPK Pathway
por: Wang, Jiarong, et al.
Publicado: (2021)

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease
por: Xu, Yanyong, et al.
Publicado: (2021)

The caveolin proteins
por: Williams, Terence M, et al.
Publicado: (2004)

Caveolins in rhabdomyosarcoma
por: Rossi, Stefania, et al.
Publicado: (2011)

Caveolin-1 is essential in the differentiation of human adipose-derived stem cells into hepatocyte-like cells via an MAPK pathway-dependent mechanism
por: GUAN, XIN, et al.
Publicado: (2016)

Resveratrol Modulates Desaturase Expression and Fatty Acid Composition of Cultured Hepatocytes
por: Kühn, Gianna, et al.
Publicado: (2018)

Hepatocyte toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease
por: Jia, Lin, et al.
Publicado: (2018)

Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice
por: Weiss, Jonathan M., et al.
Publicado: (2023)

PFOA Exposure Prior to Hepatocyte Differentiation Leads to Gene Expression Changes Implicated in Non-Alcoholic Fatty Liver Disease
por: Hanke, Stephanie, et al.
Publicado: (2021)

Curcumol inhibits ferritinophagy to restrain hepatocyte senescence through YAP/NCOA4 in non‐alcoholic fatty liver disease
por: Qi, Xiaoyu, et al.
Publicado: (2021)

Caveolin-2 associates with intracellular chlamydial inclusions independently of caveolin-1
por: Webley, Wilmore C, et al.
Publicado: (2004)

Caveolin-1 and Caveolin-2 Can Be Antagonistic Partners in Inflammation and Beyond
por: de Almeida, Cecília Jacques Gonçalves
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nfir783s6ck5ckv80h4snqfjv6